Your search returned 9 results.

Sort
Results
1.
Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31025878
Year: 2019
Citation:
  • Diabetes Technology & Therapeutics. 21(5):273-285, 2019 May.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bailey TS, Bergenstal RM, Brazg RL, Calibra Study Group, Dreon DM, Frias JP, Johnson ML, Klonoff DC, Kruger DF, Levy BL, Naik RG, Peyrot M, Ramtoola S, Rosenstock J, Serusclat P, Shearer DM, Weinstock RS, Zraick V
2.
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31186300
Year: 2019
Citation:
  • Diabetes Care. 42(9):1724-1732, 2019 09.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Altuntas Y, Aroda VR, Christiansen E, Haluzik M, Hertz CL, Jeppesen OK, Lalic NM, Morales Villegas EC, PIONEER 1 Investigators, Rosenstock J, Terauchi Y
3.
Consistent findings in glycaemic control, body weight and hypoglycaemia with iGlarLixi (insulin glargine/lixisenatide titratable fixed-ratio combination) versus insulin glargine across baseline HbA1c, BMI and diabetes duration categories in the LixiLan-L trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28386990
Year: 2017
Citation:
  • Diabetes, Obesity & Metabolism. 19(10):1408-1415, 2017 Oct.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Bergenstal RM, Bonadonna RC, Kapitza C, LixiLan-L trial investigators, Niemoeller E, Puig-Domingo M, Souhami E, Stager W, Wysham C, Yu C
4.
Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 26200237
Year: 2015
Citation:
  • Journal of Clinical Endocrinology & Metabolism. 100(10):3778-86, 2015 Oct.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Barrett-Connor E, Christophi CA, Diabetes Prevention Program, Edelstein SE, Florez JC, Goldberg RB, Kahn SE, Kim C, Knowler WC, Labrie F, Mather KJ
5.
Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31530667
Year: 2019
Citation:
  • Diabetes Care. 42(12):2262-2271, 2019 12.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Araki E, Aroda VR, Buse JB, Cariou B, Harris SB, Hoff ST, Pedersen KB, PIONEER 8 investigators, Tarp-Johansen MJ, Zinman B
6.
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 29246950
Year: 2018
Citation:
  • Diabetes Care. 41(2):258-266, 2018 02.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahmann AJ, Annett MP, Aroda VR, Capehorn M, Charpentier G, Dotta F, Henkel E, Holst AG, Lingvay I
7.
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 32139384
Year: 2020
Citation:
  • Diabetes Care. 43(5):940-947, 2020 05.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Butera NM, Camp AW, Cherrington A, Craig J, Fortmann SP, GRADE Research Group, Hollander PA, Krakoff J, Perez M, Phillips LS, Rasouli N, Sivitz WI, Tan MH, Tiktin M, Wexler DJ, Younes N
8.
Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 31530665
Year: 2019
Citation:
  • Diabetes Care. 42(11):2108-2116, 2019 11.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Blonde L, Del Prato S, Frias J, Henry R, Ji C, Niemoeller E, Rosenstock J, Shehadeh N, Souhami E
9.
A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data. MedStar authors:
  • Aroda, Vanita R
PMID:
  • 28939018
Year: 2017
Citation:
  • Journal of Diabetes & its Complications. 31(12):1719-1727, 2017 Dec.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Aroda VR, Gourgari E, Hassanzadeh H, Shoulson I, Wilhelm EE
Pages

Powered by Koha